Patents Assigned to Pangaea Biotech
  • METHOD OF DETERMINING A CHEMOTHERAPEUTIC REGIMEN FOR NON-SMALL-CELL LUNG CANCER BASED ON BRCA1 EXPRESSION
    Publication number: 20100009013
    Abstract: The present invention relates to a screening method for classifying patients and for selecting an effective chemotherapy for the treatment of a patient suffering from non-small-cell lung cancer (NSCLC), based on the use of his levels of BRCA1 expression to predict the outcome of chemotherapy.
    Type: Application
    Filed: July 1, 2009
    Publication date: January 14, 2010
    Applicant: PANGAEA BIOTECH
    Inventors: Rafael ROSELL COSTA, Miquel TARON ROCA
  • Method of determining a chemotherapeutic regimen for non small cell lung cancer based on BRCA1 expression
    Patent number: 7563570
    Abstract: The present invention relates to a screening method for classifying patients and for selecting an effective chemotherapy for the treatment of a patient suffering from non-small-cell lung cancer (NSCLC), based on the use of his levels of BRCA1 expression to predict the outcome of chemotherapy.
    Type: Grant
    Filed: October 29, 2004
    Date of Patent: July 21, 2009
    Assignee: Pangaea Biotech
    Inventors: Rafael Rosell Costa, Miquel Taron Roca